Plus Therapeutics

PSTV53

Penny Stock

$1.64arrow_drop_up2.50%$0.04

Penny Stock

PSTV53

$1.64

arrow_drop_up2.50%$0.04

Penny Stock

Performance History

Key Stats
Open	$1.51
Prev. Close	$1.60
EPS	-3.09
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$9.66M
PE Ratio	-

	LOW	HIGH
Day Range	1.50	1.64
52 Week Range	0.97	2.78

Ratios







EPS	-3.09

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Plus Therapeutics (PSTV)

Plus Therapeutics Inc (PSTV) is a biotechnology company that focuses on developing innovative therapies for rare diseases and cancer. As of the latest available data, PSTV stock price history shows that the stock has experienced fluctuations in its value over time. Investors interested in the company can check the current PSTV quote for up-to-date information on its stock price.

In the world of biotechnology, news and developments play a crucial role. Keeping up with the latest PSTV stock news can provide investors with insights into the company's progress, collaborations, and potential future growth. Additionally, PSTV stock analysis can help investors evaluate the company's financial performance, market position, and competitive landscape. It can be beneficial to rely on smart analysis tools that leverage data and advanced algorithms to provide a comprehensive assessment of PSTV stock.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Marc H. Hedrick M.B.A., M.D.
Headquarters: Austin
Employees: 17
Exchange: NASDAQ

Keep an eye on Plus Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Plus Therapeutics 's (PSTV) price per share?

The current price per share for Plus Therapeutics (PSTV) is $1.64. The stock has seen a price change of $0.04 recently, indicating a 2.5% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Plus Therapeutics (PSTV)?

For Plus Therapeutics (PSTV), the 52-week high is $2.78, which is 69.51% from the current price. The 52-week low is $0.97, the current price is 69.07% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Plus Therapeutics (PSTV) a growth stock?

Plus Therapeutics (PSTV) has shown an average price growth of 0.41% over the past three years. It has received a score of 1 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Plus Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Plus Therapeutics (PSTV) stock price performance year to date (YTD)?

As of the latest data, Plus Therapeutics (PSTV) has a year-to-date price change of -11.35%. Over the past month, the stock has experienced a price change of 5.81%. Over the last three months, the change has been -11.83%. Over the past six months, the figure is -11.83%. Looking at a longer horizon, the five-year price change stands at -98.64%.

help

Is Plus Therapeutics (PSTV) a profitable company?

Plus Therapeutics (PSTV) has a net income of -$13.32M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 84.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -289.05% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $4.91M, although specific revenue growth data is currently not available. The gross profit is $4.17M. Operating income is noted at -$13.32M. Furthermore, the EBITDA is -$13.47M.

help

What is the market capitalization of Plus Therapeutics (PSTV)?

Plus Therapeutics (PSTV) has a market capitalization of $9.67M. The average daily trading volume is 50.29K, indicating the stock's liquidity and investor engagement.